Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Timothy Ashby

Concepts (200)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
40
2025
3013
2.820
Why?
High-Throughput Nucleotide Sequencing
7
2022
178
1.110
Why?
Genomics
10
2023
266
0.830
Why?
Mutation
14
2022
1331
0.810
Why?
Software
4
2021
281
0.800
Why?
Plasma Cells
7
2025
233
0.740
Why?
Monoclonal Gammopathy of Undetermined Significance
4
2025
123
0.630
Why?
Tumor Microenvironment
4
2024
257
0.570
Why?
Clonal Evolution
4
2020
57
0.540
Why?
Computational Biology
4
2020
209
0.520
Why?
Gene Expression Regulation, Neoplastic
6
2024
853
0.500
Why?
Algorithms
4
2020
673
0.470
Why?
Neoplasm Recurrence, Local
5
2024
639
0.440
Why?
Humans
48
2025
52441
0.400
Why?
Prognosis
13
2025
2100
0.390
Why?
Translocation, Genetic
7
2022
266
0.380
Why?
Neoplasms
2
2020
1314
0.380
Why?
Gene Expression Profiling
10
2025
1099
0.380
Why?
Positron-Emission Tomography
3
2025
297
0.370
Why?
Hematopoietic Stem Cell Transplantation
3
2024
600
0.360
Why?
Osteolysis
2
2022
74
0.360
Why?
Models, Molecular
1
2013
356
0.360
Why?
Diffusion Magnetic Resonance Imaging
2
2025
131
0.360
Why?
Chromosome Aberrations
3
2023
295
0.340
Why?
Genome, Human
3
2021
121
0.340
Why?
Osteocytes
2
2024
219
0.340
Why?
Evolution, Molecular
2
2021
98
0.330
Why?
Signal Transduction
4
2024
1724
0.330
Why?
Proteins
1
2013
353
0.320
Why?
Bone Marrow
3
2020
354
0.300
Why?
Epigenomics
2
2021
75
0.290
Why?
Disease Progression
8
2025
870
0.280
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2020
1020
0.260
Why?
RANK Ligand
2
2024
188
0.250
Why?
Gene Rearrangement
2
2023
76
0.230
Why?
Oncogenes
3
2021
61
0.230
Why?
Chemokine CCL3
1
2024
12
0.220
Why?
HMGB1 Protein
1
2024
21
0.220
Why?
Chemokine CXCL12
1
2024
35
0.220
Why?
Bone Resorption
2
2024
300
0.210
Why?
Burkitt Lymphoma
1
2023
27
0.200
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2023
12
0.200
Why?
Gene Dosage
2
2020
73
0.200
Why?
Neoplasm, Residual
2
2025
169
0.190
Why?
Epigenesis, Genetic
3
2023
396
0.190
Why?
Proto-Oncogene Proteins c-akt
1
2023
168
0.190
Why?
Proto-Oncogene Proteins B-raf
2
2020
75
0.190
Why?
Neoplasm Proteins
2
2021
328
0.180
Why?
Drug Resistance, Neoplasm
1
2024
336
0.180
Why?
Cell Communication
1
2022
74
0.180
Why?
Mice
8
2024
5899
0.180
Why?
Telomere Homeostasis
1
2021
11
0.180
Why?
Polycomb Repressive Complex 2
1
2021
47
0.170
Why?
Transcriptome
3
2025
357
0.170
Why?
Ubiquitination
1
2021
57
0.170
Why?
Chromosome Deletion
2
2023
138
0.170
Why?
Loss of Heterozygosity
2
2018
78
0.170
Why?
Lymphoma, B-Cell
1
2021
60
0.170
Why?
Genes, Tumor Suppressor
2
2021
73
0.170
Why?
Sequence Analysis, DNA
2
2018
220
0.160
Why?
Cell Cycle
1
2021
236
0.160
Why?
Cell Cycle Proteins
1
2021
168
0.160
Why?
B-Lymphocytes
1
2021
178
0.160
Why?
Lymphoma, Follicular
1
2020
27
0.160
Why?
Cell Line, Tumor
4
2024
1429
0.160
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.160
Why?
Female
13
2025
28277
0.160
Why?
Leukemia, Plasma Cell
1
2020
33
0.160
Why?
Aged
10
2025
10242
0.160
Why?
Gene Regulatory Networks
1
2020
112
0.150
Why?
Genes, myc
1
2019
39
0.150
Why?
Middle Aged
10
2025
13133
0.150
Why?
Aged, 80 and over
6
2025
3449
0.150
Why?
Tumor Suppressor Protein p53
2
2017
224
0.150
Why?
Transplantation, Autologous
4
2024
479
0.140
Why?
Mutagenesis
1
2018
58
0.140
Why?
Genome
1
2018
61
0.140
Why?
Male
13
2025
26874
0.140
Why?
Homologous Recombination
1
2018
44
0.140
Why?
Chromosomes, Human, Pair 17
1
2017
35
0.130
Why?
Flow Cytometry
1
2018
396
0.130
Why?
Survival Rate
4
2021
944
0.130
Why?
Animals
8
2024
13485
0.130
Why?
DNA Repair
1
2018
194
0.130
Why?
DNA Copy Number Variations
3
2022
116
0.120
Why?
Adult
8
2025
14205
0.120
Why?
Remission Induction
3
2021
218
0.110
Why?
Genes, Neoplasm
1
2015
31
0.110
Why?
Pattern Recognition, Automated
1
2015
39
0.110
Why?
Cluster Analysis
1
2015
236
0.110
Why?
Follow-Up Studies
4
2021
2294
0.110
Why?
Databases, Protein
1
2013
29
0.100
Why?
Protein Structure, Secondary
1
2013
73
0.100
Why?
Sequence Alignment
1
2013
121
0.100
Why?
Amino Acid Sequence
1
2013
576
0.090
Why?
T-Lymphocytes
2
2024
318
0.090
Why?
Chromatin
2
2023
143
0.090
Why?
Breast Neoplasms
1
2020
1203
0.090
Why?
Adenocarcinoma
1
2015
403
0.090
Why?
Mutation Rate
2
2021
36
0.080
Why?
In Situ Hybridization, Fluorescence
2
2023
262
0.080
Why?
Tumor Burden
2
2020
132
0.080
Why?
Alleles
2
2021
279
0.080
Why?
Clone Cells
2
2021
76
0.080
Why?
Proto-Oncogene Proteins p21(ras)
2
2021
67
0.080
Why?
Histones
2
2021
315
0.070
Why?
DNA, Neoplasm
2
2020
146
0.070
Why?
DNA Mutational Analysis
2
2020
179
0.070
Why?
Lung Neoplasms
1
2015
643
0.070
Why?
Treatment Outcome
4
2020
5508
0.070
Why?
DNA Methylation
2
2023
573
0.070
Why?
Recurrence
2
2021
680
0.070
Why?
Genomic Instability
2
2018
87
0.060
Why?
Risk Factors
3
2021
3971
0.060
Why?
Cell Proliferation
2
2021
1013
0.060
Why?
ROC Curve
1
2025
249
0.060
Why?
Internet
2
2018
262
0.050
Why?
Killer Cells, Natural
1
2024
111
0.050
Why?
Ferritins
1
2024
36
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
140
0.050
Why?
Xenograft Model Antitumor Assays
1
2024
218
0.050
Why?
Antibodies
1
2024
144
0.050
Why?
Proteasome Inhibitors
1
2024
101
0.050
Why?
Integrin beta Chains
1
2023
14
0.050
Why?
Integrins
1
2023
31
0.050
Why?
Oxidative Phosphorylation
1
2023
46
0.050
Why?
B-Cell Maturation Antigen
1
2024
95
0.050
Why?
Cytogenetic Analysis
1
2023
79
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cystatin M
1
2022
17
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
95
0.050
Why?
Immunoglobulins
1
2023
76
0.050
Why?
Forkhead Transcription Factors
1
2023
120
0.050
Why?
Retrospective Studies
2
2025
6694
0.050
Why?
Phylogeny
1
2022
229
0.040
Why?
Syndecan-1
1
2021
73
0.040
Why?
Spliceosomes
1
2021
10
0.040
Why?
Transcriptional Activation
1
2021
127
0.040
Why?
RNA Splicing
1
2021
43
0.040
Why?
Cyclin D2
1
2020
21
0.040
Why?
Alternative Splicing
1
2021
61
0.040
Why?
Spatio-Temporal Analysis
1
2020
11
0.040
Why?
Aneuploidy
1
2020
19
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
ras Proteins
1
2020
62
0.040
Why?
Histone Code
1
2020
32
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
31
0.040
Why?
Cyclin D1
1
2020
59
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
56
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
76
0.040
Why?
Phosphoproteins
1
2021
123
0.040
Why?
Single-Cell Analysis
1
2020
71
0.040
Why?
Ecosystem
1
2021
99
0.040
Why?
Mice, Transgenic
1
2021
566
0.040
Why?
Cell Differentiation
1
2022
667
0.040
Why?
DNA
1
2023
544
0.040
Why?
Osteoclasts
1
2022
423
0.040
Why?
Protein Disulfide-Isomerases
1
2019
12
0.040
Why?
Genes, Immunoglobulin Heavy Chain
1
2019
13
0.040
Why?
Melphalan
1
2020
176
0.040
Why?
Neoplasm Invasiveness
1
2020
278
0.040
Why?
Osteogenesis
1
2022
368
0.040
Why?
Genetic Variation
1
2020
226
0.040
Why?
Combined Modality Therapy
1
2021
641
0.040
Why?
Multivariate Analysis
1
2021
601
0.040
Why?
Disease Models, Animal
1
2024
1483
0.040
Why?
Maintenance Chemotherapy
1
2019
52
0.040
Why?
Apoptosis
1
2024
1120
0.040
Why?
Cell Survival
1
2020
598
0.040
Why?
Promoter Regions, Genetic
1
2020
465
0.040
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
7
0.030
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
26
0.030
Why?
Reproducibility of Results
1
2021
1223
0.030
Why?
Genome-Wide Association Study
1
2018
184
0.030
Why?
Information Dissemination
1
2018
84
0.030
Why?
Fibroblast Growth Factors
1
2017
48
0.030
Why?
STAT3 Transcription Factor
1
2017
89
0.030
Why?
Mitogen-Activated Protein Kinases
1
2017
152
0.030
Why?
Dose-Response Relationship, Drug
1
2020
1365
0.030
Why?
Prospective Studies
1
2023
2433
0.030
Why?
Thalidomide
1
2019
376
0.030
Why?
Proportional Hazards Models
1
2018
446
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Kaplan-Meier Estimate
1
2018
485
0.030
Why?
Genes, p53
1
2016
50
0.030
Why?
Cohort Studies
1
2020
1576
0.030
Why?
Models, Genetic
1
2016
173
0.030
Why?
Antineoplastic Agents
1
2024
1216
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
147
0.030
Why?
Survival Analysis
1
2017
656
0.030
Why?
Stem Cell Transplantation
1
2016
188
0.030
Why?
Dogs
1
2015
183
0.030
Why?
Databases, Genetic
1
2015
82
0.030
Why?
Time Factors
1
2021
2987
0.030
Why?
Sequence Analysis, RNA
1
2015
96
0.030
Why?
Genetic Testing
1
2015
130
0.030
Why?
Longitudinal Studies
1
2016
756
0.030
Why?
Child
1
2023
7194
0.020
Why?
Ashby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description